ITI Pharma and Healthcare Fund Regular vs Kotak Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Kotak Healthcare Fund - Regular (G)
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹208 Cr | ₹406 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 08 Nov 2021 | 11 Dec 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | NIFTY Healthcare TRI |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.39 |
Manager | Rohan Korde | Abhishek Bisen |
ISIN Code | INF00XX01BL5 | INF174KA1PW4 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Kotak Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
---|---|---|
1 Month | -7.38% | -7.43% |
6 Month | -2.25% | -1% |
1 Year | 15.33% | 12.75% |
3 Year | 17.62% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
---|---|---|
6 Month | - | - |
1 Year | 15.23% | 14.39% |
3 Year | 26.81% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
---|---|---|
1 Year | 24.79% | 31.01% |
3 Year | 19.26% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
---|---|---|
Standard Deviation | 14.52% | - |
Sharp | - | - |
Beta | - | - |
Alpha | - | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
---|---|---|
Name | Rohan Korde | Abhishek Bisen |
Total AUM | ₹4626 Cr | ₹0 Cr |
Fund Manage | 10 | 33 |
ITI Pharma and Healthcare Fund Regular - Growth | Kotak Healthcare Fund - Regular (G) |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
---|---|---|
Others | 1.8 | 3.31 |
Large Cap | 38.11 | 51.29 |
Mid Cap | 26.43 | 22.8 |
Small Cap | 33.66 | 24.27 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Kotak Healthcare Fund - Regular (G) |
---|---|---|
Others | 1.8 | 3.31 |
Pharmaceuticals & Biotechnology | 77 | 79.49 |
Healthcare Services | 18.01 | 17.64 |
Chemicals & Petrochemicals | 0.96 | - |
Fertilizers & Agrochemicals | 1.03 | - |
Insurance | 1.2 | 1.23 |
Top Comparisons
Kotak Gilt-Investment Regular-Growth
3Y Returns6.09%
Kotak Gilt-Investment Regular-Growth
3Y Returns6.09%
HDFC Hybrid Debt Fund - Growth Plan
3Y Returns9.49%
Nippon India Hybrid Bond Fund-Growth Plan
3Y Returns7.46%
Kotak Credit Risk Fund - Growth
3Y Returns4.89%
Nippon India Credit Risk Fund - Growth Plan
3Y Returns6.76%
HSBC Liquid Fund - Regular Growth
3Y Returns6.53%
DSP Liquidity Fund - Regular Plan - Growth
3Y Returns6.53%